| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/14/2005 | US20050153398 Transgenic cell for use as bioreactor in generation of preferential proteins |
| 07/14/2005 | US20050153397 Methods for producing polypeptides in Aspergillus mutant cells |
| 07/14/2005 | US20050153396 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/14/2005 | US20050153395 Unique integrin binding site in connective tissue growth factor (CTGF) |
| 07/14/2005 | US20050153394 Targeting construct for use as tool in enhanced transfer gene sequences into cells; bioreactors; improving exogenous gene expression |
| 07/14/2005 | US20050153393 Chimeric protein fusion comprising signal peptides and non-polar carboxy tail; improvng stability of proteins; directed protein evolution |
| 07/14/2005 | US20050153392 Transgenesis with humanized immunoglobulin loci |
| 07/14/2005 | US20050153391 Polypeptides capable of binding to G protein coupled receptors as well as DNA encoding for such polypeptides; receptor binding assays; drug screening; obesity; prolactin production inhibitors |
| 07/14/2005 | US20050153378 Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same |
| 07/14/2005 | US20050153375 CEA/NCA-based differentiation cancer therapy |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/14/2005 | US20050153357 For detection of molecular interactions between immobilized ligands and receptors; immobilization on solid phase, biochemical conjugation, cleavage |
| 07/14/2005 | US20050153355 Water-soluble rhodamine dye conjugates |
| 07/14/2005 | US20050153354 Detection and quantification of analytes in solution using polymers |
| 07/14/2005 | US20050153350 Method for immobilizing a biomolecule on a solid substrate at a high density by using the substrate having an activated carboxyl group on a surface thereof and microarray produced using the method |
| 07/14/2005 | US20050153348 Using membrane protein expression pattern as diagnostic and prognostic tool in detection of breast, colon and lung tissue cell proliferative disorders |
| 07/14/2005 | US20050153343 Solid phase synthesis; gene expression libraries; high throughput assay |
| 07/14/2005 | US20050153342 Using cell-adhesion matrix to isolate and propagate tumlor cells; blood filters |
| 07/14/2005 | US20050153340 Ribonuclease for use as tool in treatment and prevention of metabolic disorders |
| 07/14/2005 | US20050153339 Modified shine-dalgarno sequences and methods of use thereof |
| 07/14/2005 | US20050153338 Using polymerase chain chimerization to direct evolution of enhanced biopolymer molecules; directed protein evolution |
| 07/14/2005 | US20050153337 iRNA conjugates |
| 07/14/2005 | US20050153335 Expression vector comprising nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatmment of cell proliferative, inflammatory and nervous system disorders |
| 07/14/2005 | US20050153333 Selective terminal tagging of nucleic acids |
| 07/14/2005 | US20050153332 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 07/14/2005 | US20050153330 Novel DKR polypeptides |
| 07/14/2005 | US20050153328 Method and markers for determining the genotype of horned/polled cattle |
| 07/14/2005 | US20050153327 Human ataxin-1-like polypeptide IMX97018 |
| 07/14/2005 | US20050153326 Method for synthesizing cDNA |
| 07/14/2005 | US20050153318 Microarray method of genotyping multiple samples at multiple loci |
| 07/14/2005 | US20050153315 Nucleotide sequences coding polypeptide comprising methylarginase activities for use in identifying modulator for prevention and treatment of ischemia-reperfusion injuries, cancer, hypotension, multi-organ failure, arthritis, skin, inflammatory, cardiac and/or migraine disorders |
| 07/14/2005 | US20050153312 Nucleic acid compositions and methods of introducing nucleic acids into cells |
| 07/14/2005 | US20050153303 Method of mutagenic chain reaction |
| 07/14/2005 | US20050153302 Method for comprehensive identification of cell lineage specific genes |
| 07/14/2005 | US20050153297 Method for determining oligonucleotide concentration |
| 07/14/2005 | US20050153296 Method and devices for dna methylation analysis |
| 07/14/2005 | US20050153295 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
| 07/14/2005 | US20050153292 Method to determine in vivo nucleic acid levels |
| 07/14/2005 | US20050153287 Nr3b nmda receptor subunit compositions and related methods |
| 07/14/2005 | US20050153283 Generating circular sequence variants from heteroduplex polynucleotides using non-mismatch-specific nucleases; enhancing allelic variation |
| 07/14/2005 | US20050153281 Incubating a cell containing an HCV RNA having a heterologous polynucleotide with a sequence encoding a transactivator; the cell has a transactivated coding region with an operator sequence linked to it that encodes a detectable marker; transactivator alters transcription of the coding region |
| 07/14/2005 | US20050153280 Viral propagation system and uses thereof |
| 07/14/2005 | US20050153057 Lipopolysaccharide for influenza vaccines and respiratory system disorders |
| 07/14/2005 | US20050153047 Novel melon plants |
| 07/14/2005 | US20050152995 comprising contacting tissues with agents that prevents glial scar formation and optionally agent that increases bcl-2 protein levels in neurons |
| 07/14/2005 | US20050152984 Membrane scaffold proteins |
| 07/14/2005 | US20050152964 Drug/lipid/polycation complexes; gene therapy |
| 07/14/2005 | US20050152959 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell |
| 07/14/2005 | US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis |
| 07/14/2005 | US20050152921 Modified CpG oligodeoxynucleotide with improved immunoregulatory function |
| 07/14/2005 | US20050152920 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 07/14/2005 | US20050152917 Fusion protein for use in the treatment of viral diseases |
| 07/14/2005 | US20050152916 Antigen presenting system and methods for activation of T-cells |
| 07/14/2005 | US20050152904 Novel P-selectin glycoprotein ligand (PSGL-1) binding protein and uses therefor |
| 07/14/2005 | US20050152897 Methods for inducing T cell tolerance to a tissue or organ graft |
| 07/14/2005 | US20050152888 in a ubiquitin-independent manner comprising complexing proteasome-localizing agents with polypeptides and allowing degradation of the polypeptide |
| 07/14/2005 | US20050152878 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 07/14/2005 | US20050152876 administering PTX3 to increase the amount or activity of Pentraxin 3 in the cumulous oophorus and/or the extracellular matrix of the cumulous oophorus |
| 07/14/2005 | US20050152874 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells |
| 07/14/2005 | US20050152871 treating the subject in need with one or more chemokines and/or a DNA damaging agent inducing said chemokine(s); |
| 07/14/2005 | US20050152838 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 07/14/2005 | US20050152039 Apparatus and method for fabricating, sorting, and integrating materials with holographic optical traps |
| 07/14/2005 | DE10359190A1 Electrofusion of cells, useful e.g. in cancer therapy or monoclonal antibody production, comprises exposing cells, flowing one at a time to a plane, to an aligning field and then a fusion pulse |
| 07/14/2005 | DE10358407A1 Antiapoptorisch wirksame Aptamere (zur Therapie von Herz-Kreislauf Erkrankungen) Antiapoptorisch effective aptamers (for the treatment of cardiovascular diseases) |
| 07/14/2005 | DE10131145B4 Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen Composition for cell-specific transfer of drugs |
| 07/14/2005 | CA2805816A1 Transgenic plants expressing a putative palmitoyl protein thioesterase |
| 07/14/2005 | CA2804953A1 Plant activation of insect toxin |
| 07/14/2005 | CA2552150A1 Means for stimulation and activation of hair growth by il-15 |
| 07/14/2005 | CA2551920A1 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 07/14/2005 | CA2551915A1 Il-7 fusion proteins |
| 07/14/2005 | CA2551912A1 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof |
| 07/14/2005 | CA2551696A1 Immunopotentiator and method of enhancing immunoactivity using the same |
| 07/14/2005 | CA2551489A1 Multi plasmid system for the production of influenza virus |
| 07/14/2005 | CA2551100A1 Compositions and methods for combined therapy of disease |
| 07/14/2005 | CA2551094A1 Methods and compositions for identifying rna-binding proteins |
| 07/14/2005 | CA2551026A1 Methods for producing a549 cell lines stable in serum-free medium suspension culture |
| 07/14/2005 | CA2551024A1 Maize metallothionein 2 promoter and methods of use |
| 07/14/2005 | CA2551023A1 Maize metallothionein promoter |
| 07/14/2005 | CA2551011A1 Plant activation of insect toxin |
| 07/14/2005 | CA2551008A1 Anti-cd40 antibody mutants |
| 07/14/2005 | CA2550933A1 Methods for identifying functional antibodies |
| 07/14/2005 | CA2550927A1 A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection |
| 07/14/2005 | CA2550727A1 Treatment of coronary or peripheral ischemia |
| 07/14/2005 | CA2550651A1 Novel anti-il 13 antibodies and uses thereof |
| 07/14/2005 | CA2550455A1 Haemophilus influenzae type iv pili |
| 07/14/2005 | CA2550376A1 Novel carotenoids ketolases |
| 07/14/2005 | CA2548757A1 Monovalent antibody fragments useful as therapeutics |
| 07/13/2005 | EP1553512A1 Information processing system using base sequence relevant information |
| 07/13/2005 | EP1553415A1 Method for immobilizing a biomolecule on a solid substrate at a high density by using the substrate having an activated carboxyl group on a surface thereof and microarray produced using the method |
| 07/13/2005 | EP1553190A2 Mutations in and genomic structure of HERG - a long QT syndrome gene |
| 07/13/2005 | EP1553189A1 T7 amplification and cDNA klenow labeling for expression (TAcKLE) analysis with oligonucleotide microarrays |
| 07/13/2005 | EP1553184A1 Process for producing tripeptide or higher peptide |
| 07/13/2005 | EP1553183A1 Nucleic acid encoding mirafiori lettuce virus protein and utilization thereof |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553181A1 Gene expression inhibition and uses thereof |
| 07/13/2005 | EP1553180A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 07/13/2005 | EP1553179A1 Mouse-origin proteins forming domain or use thereof |
| 07/13/2005 | EP1553178A1 Tumor-lysing virus growing selectively in tumor cells |
| 07/13/2005 | EP1553177A1 Method of designing physiologically active peptide and use thereof |
| 07/13/2005 | EP1553176A1 Apparatus for introducing biological material, method of introducing biological material and magnetic support for introducing biological material |